Skip to main content
. 2017 Sep 4;4(4):402–408. doi: 10.1002/ehf2.12204

Figure 4.

Figure 4

Effect of angiotensin‐converting enzyme inhibitors (ACE‐Is) and angiotensin receptor blockers (RCBs) on cardiovascular mortality in patients with heart failure with preserved ejection fraction. CI, confidence interval; RCT, randomized clinical trial; RR, relative risk.